跳至主要内容
临床试验/NCT05504681
NCT05504681招募中不适用

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Baptist Health South Florida1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
1
主要终点
Change in Verbal Fluency (Neurocognitive Decline)

研究概览

简要总结

This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All adult (18+) patients with central nervous system (CNS) tumors, both primary brain malignancies and brain metastases, treated with radiotherapy (partial brain, stereotactic radiosurgery, stereotactic fractionated radiotherapy, or whole-brain radiotherapy), surgery, and/or antineoplastic therapy and followed thereafter at Miami Cancer Institute (MCI)
  • Life expectancy ≥ 6 months
  • Willingness to participate in ongoing registration study

排除标准

  • Patients receiving radiotherapy to the brain for functional disease (arteriovenous malformations, trigeminal neuralgia, essential tremors, etc.)
  • Pediatric patients (<18 years old), pregnant women, and prisoners.

结局指标

主要结局

Change in Verbal Fluency (Neurocognitive Decline)

时间窗: Baseline, 2, 4, 6, 12, 18, 24 months

This will be measured by the "Words That Start With" test. The total number of words correctly generated (no numbers, no proper names) by the subject will be recorded to generate their score. A higher score indicates better functioning.

Change in Fine motor and speed (Neurocognitive Decline)

时间窗: Baseline, 2, 4, 6, 12, 18, 24 months

This will be measured by the "Numbers Ordering" test. This test assesses visual scanning and motor tracking requiring focused attention. Subjects are required to sequentially connect numbered dots in ascending order that are randomly scattered on the screen in consecutive order. The total time in seconds to complete the array will be recorded as the score result. A lower score indicates better functioning.

Change in Attention and Speed of Processing (Neurocognitive Decline)

时间窗: Baseline, 2, 4, 6, 12, 18, 24 months

This will be measured by the "Symbols Matching" test. Subjects will be asked to match symbols and corresponding numbers during 90 seconds. The score will be calculated by totaling the number of correct answers during the allotted time. A higher score indicates better functioning.

Change in Executive functions (Neurocognitive Decline).

时间窗: Baseline, 2, 4, 6, 12, 18, 24 months

This will be measured by "Numbers and Letters Ordering" test. This test includes a divided attention component requiring mental flexibility (i.e., executive function). On this subtest, dots with numbers and letters are randomly scattered. Subjects are required to alternate between connecting numbers and letters in an ascending sequential order. Subjects will order numbers and letters from 1 to 13 and from A to M by tapping them as fast as possible in consecutive and alternating order. The total time in whole seconds to complete the array will be recorded. A lower score indicates better functioning.

Change in Learning and memory (Neurocognitive Decline)

时间窗: Baseline, 2, 4, 6, 12, 18, 24 months

Learning and memory will be assessed by the number of correct responses (the total number of words correctly recalled). The "Verbal Recall" test will be used to measure the number of correct responses over 3 trials, the "Verbal Revision" will be used to measure the number of total correct responses, and the "Verbal Recognition" test will be used to measure number of correct responses minus the incorrect responses. Change is calculated as baseline score subtracted from post-baseline score over time.

次要结局

未报告次要终点

研究者

发起方
Baptist Health South Florida
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Integration of Neurocognitive Biomarkers Into a... | 临床试验